bicalutamide and mk 2866

bicalutamide has been researched along with mk 2866 in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's4 (80.00)24.3611
2020's1 (20.00)2.80

Authors

AuthorsStudies
Bohl, CE; Dalton, JT; Duke, CB; Jones, A; Miller, DD1
Bassetto, M; Brancale, A; Ferla, S; Kandil, S; McGuigan, C; Pertusati, F; Westwell, AD1
Wang, S; Xiang, W1
Bovee, TF; de Rijke, E; Essers, ML; Rijk, JC; Sterk, SS; Thevis, M; van Ginkel, LA1
Bassetto, M; Brancale, A; Ferla, S; Khandil, S; McGuigan, C; Pertusati, F; Westwell, AD1

Reviews

1 review(s) available for bicalutamide and mk 2866

ArticleYear
Therapeutic Strategies to Target the Androgen Receptor.
    Journal of medicinal chemistry, 2022, 07-14, Volume: 65, Issue:13

    Topics: Androgen Antagonists; Androgen Receptor Antagonists; Humans; Male; Prostatic Neoplasms, Castration-Resistant; Receptors, Androgen

2022

Other Studies

4 other study(ies) available for bicalutamide and mk 2866

ArticleYear
Unexpected binding orientation of bulky-B-ring anti-androgens and implications for future drug targets.
    Journal of medicinal chemistry, 2011, Jun-09, Volume: 54, Issue:11

    Topics: Androgen Antagonists; Androgen Receptor Antagonists; Androgens; Crystallography, X-Ray; Drug Design; Drug Resistance, Neoplasm; Humans; Male; Molecular Structure; Molecular Targeted Therapy; Prostatic Neoplasms; Protein Binding; Receptors, Androgen; Structure-Activity Relationship

2011
Design and synthesis of novel bicalutamide and enzalutamide derivatives as antiproliferative agents for the treatment of prostate cancer.
    European journal of medicinal chemistry, 2016, Aug-08, Volume: 118

    Topics: Anilides; Antineoplastic Agents; Benzamides; Caco-2 Cells; Cell Line, Tumor; Cell Proliferation; Chemistry Techniques, Synthetic; Drug Design; Drug Resistance, Neoplasm; Humans; Male; Microsomes, Liver; Molecular Docking Simulation; Molecular Dynamics Simulation; Nitriles; Permeability; Phenylthiohydantoin; Prostatic Neoplasms; Protein Conformation; Receptors, Androgen; Tosyl Compounds

2016
Selective androgen receptor modulators: in vitro and in vivo metabolism and analysis.
    Food additives & contaminants. Part A, Chemistry, analysis, control, exposure & risk assessment, 2013, Volume: 30, Issue:9

    Topics: Acetamides; Acetanilides; Amides; Aminophenols; Androgen Receptor Antagonists; Anilides; Animals; Cattle; Cell Line; Drug Evaluation, Preclinical; Drug Stability; Drugs, Investigational; Humans; Lactates; Limit of Detection; Male; Metabolic Detoxication, Phase I; Metabolic Detoxication, Phase II; Microsomes, Liver; Nitriles; Nonsteroidal Anti-Androgens; Quinolones; Reproducibility of Results; Species Specificity; Tosyl Compounds; Veterinary Drugs

2013
A new series of bicalutamide, enzalutamide and enobosarm derivatives carrying pentafluorosulfanyl (SF
    European journal of medicinal chemistry, 2019, Oct-15, Volume: 180

    Topics: Anilides; Animals; Antineoplastic Agents; Benzamides; Cell Line, Tumor; Cell Proliferation; CHO Cells; Cricetulus; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Ether-A-Go-Go Potassium Channels; Humans; Hydrocarbons, Fluorinated; Male; Mice; Mice, Nude; Molecular Structure; Neoplasms, Experimental; Nitriles; Phenylthiohydantoin; Prostatic Neoplasms; Structure-Activity Relationship; Sulfhydryl Compounds; Tosyl Compounds

2019